Repositori institucional de la UVic-UCC: Enviaments recents
Ara mostrant els elements 5021-5040 de 7195
-
Cicle de conferències 2014-2015. Lecture.The Microbiome in HIV Infection
(2015-02-17)HIV / AIDS infection is a major health problem with more than 30 million people affected worldwide and more than 2 million new infections each year. Fortunately, antiretroviral treatments manage to ... -
Punt de llibre de Sant Jordi 2015
(2015-04-23)Punt de llibre fet des de la Biblioteca en motiu de la diada de Sant Jordi del 2015. -
4a Jornada de Multimèdia
(2015-04-14) -
Perfil de resistencias y barrera genética de dolutegravir
(2015)Dolutegravir tiene un perfil de resistencias significativamente distinto al de anteriores inhibidores de la integrasa. Es activo in vitro frente a VIH-1 (virus de la inmunodeficiencia humana-1) portador ... -
Monotherapy with boosted PIs as an ART simplification strategy in clinical practice
(2015)Background: Data on the efficacy of simplifying therapy using darunavir/ritonavir and lopinavir/ritonavir monotherapy in clinical practice remain limited. Methods: A retrospective single-centre study ... -
Reduced darunavir dose is as effective in maintaining HIV suppression as the standard dose in virologically suppressed HIV-infected patients: a randomized clinical trial
(2015)Objectives: Maximizing ART efficiency is of growing interest. This study assessed the efficacy, safety, pharmacokinetics and economics of a darunavir dose-reduction strategy. Methods: This was a ... -
3r Concurs de fotografia : La meva foto de la ciència
(2015-03)Programa del 3r Concurs fotogràfic adreçat als infants on Les fotografies participants han de plasmar allò que l'infant ha viscut en una activitat científica escolar. Les imatges han de reflectir les ... -
Espaiciència!
(2015-03-18)EspaiCiència és una iniciativa per donar a conèixer a la ciutadania, i molt especialment els més joves, la recerca i la innovació que es du a terme a les nostres universitats, centres de recerca, empreses, ... -
Effect of maraviroc on non-R5 tropic HIV-1: refined analysis of subjects from the phase IIb study A4001029
(2015)We characterized maraviroc susceptibility of dual/mixed tropic viruses from subjects enrolled onto phase IIb study A4001029. Maraviroc baseline plasma samples from 13 multidrugexperienced subjects ... -
7a. Jornada de Mecatrònica : Mecatrònica aplicada a les energies renovables
(2015)Tríptic de la 7a Jornada de la Mecatrònica : Modelització i simulació de sistemes, celebrada el 26 de març de 2015 a Ripoll i Vic. La jornada, adreçada a estudiants, professors i empreses interessats ... -
Patterns of impact resulting from a 'sit less, move more' web-based program in sedentary office employees
(2015)Purpose Encouraging office workers to ‘sit less and move more’ encompasses two public health priorities. However, there is little evidence on the effectiveness of workplace interventions for reducing ... -
Frailty, severity, progression and shared decision-making: A pragmatic framework for the challenge of clinical complexity at the end of life
(2015)The current epidemiological context features progressive ageing of the population and an increasing number of multi-morbid persons mostly affected by advanced chronic diseases. This perspective determines ... -
Gp120/CD4 blocking antibodies are frequently elicited in ART-naïve chronically HIV-1 infected individuals
(2015)Antibodies with the ability to block the interaction of HIV-1 envelope glycoprotein (Env) gp120 with CD4, including those overlapping the CD4 binding site (CD4bs antibodies), can protect from infection ... -
The HLA-C*04:01/KIR2DS4 gene combination and human leukocyte antigen alleles with high population frequency drive rate of HIV disease progression
(2015)Objective: The objective of this study is to identify human leukocyte antigen (HLA) class I and killer-cell immunoglobulin-like receptor (KIR) genotypes associated with different risks for HIV acquisition ... -
A human immune data-informed vaccine concept elicits strong and broad T-cell specificities associated with HIV-1 control in mice and macaques
(2015)Background: None of the HIV T-cell vaccine candidates that have reached advanced clinical testing have been able to induce protective T cell immunity. A major reason for these failures may have been ...